Federated Hermes’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-75
Closed -$6K 2385
2020
Q3
$6K Buy
75
+46
+159% +$3.07K ﹤0.01% 2017
2020
Q2
$2K Sell
29
-118,763
-100% -$6.53M ﹤0.01% 2115
2020
Q1
$4.99M Buy
118,792
+9,340
+9% +$428K 0.01% 626
2019
Q4
$4.97M Sell
109,452
-1,666
-1% -$78.8K 0.01% 774
2019
Q3
$5.09M Sell
111,118
-42,151
-28% -$2.37M 0.01% 780
2019
Q2
$8.99M Buy
153,269
+59,457
+63% +$3.07M 0.02% 618
2019
Q1
$4.21M Buy
+93,812
New +$4.3M 0.01% 831
2016
Q1
Sell
-102,370
Closed -$1.95M 2202
2015
Q4
$1.95M Sell
102,370
-462,522
-82% -$9.43M 0.01% 880
2015
Q3
$10.8M Buy
564,892
+772
+0.1% +$26.2K 0.03% 423
2015
Q2
$26.2M Buy
564,120
+22,310
+4% +$968K 0.08% 262
2015
Q1
$23.7M Buy
+541,810
New +$25.2M 0.07% 268
2013
Q3
Sell
-263,220
Closed -$20.3M 1790
2013
Q2
$20.3M Buy
+263,220
New +$21.5M 0.08% 202

Other funds holding ARNA

Federated Hermes's ARNA Position: Q4 2020 in Review

Federated Hermes sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 75 shares — an estimated $6K sold.

Federated Hermes first reported a position in ARNA in Q2 2013 and held it in 12 quarters. The position peaked at $26.2M in Q2 2015. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Federated Hermes reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 75 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $6K.
  • Federated Hermes first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Federated Hermes's Arena Pharmaceuticals Inc position peaked at $26.2M in Q2 2015.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.